Search Results - Richard Borrelli
- Showing 1 - 2 results of 2
-
1
Evaluating vaccination dosing strategies for SARS-CoV-2 in patients at high-risk for allergic reactions: Insights from vaccination campaign by Stefania Nicola, MD, Iuliana Badiu, MD, Nicolò Rashidy, MD, Elena Saracco, MD, Erika Montabone, MD, Luca Lo Sardo, MD, Marzia Boem, MD, Valentina Marmora, MD, Federica Corradi, MD, Andrea Ricotti, MSc, MPH, Richard Borrelli, MD, Giovanni Rolla, MD, Simone Negrini, MD, PhD, Luisa Brussino, MD
Published 2025-08-01Background: The COVID-19 pandemic significantly increased the demand for allergy consultations to evaluate the risk of hypersensitivity reactions in patients either before receiving their first dose of an anti-SARS-CoV-2 vaccine (Group 1) or following suspected allergic reactions after vaccination (...
Get full text
Article -
2
Development and implementation of Phleos, a web-based tool for the data collection on Hypereosinophilic syndrome: the Italian Network on HES (INHES) study protocol by Stefania Nicola, Stefania Nicola, Marco Caminati, Marco Caminati, Richard Borrelli, Luca Lo Sardo, Federica Corradi, Iuliana Badiu, Angelo Vacca, Palma Carlucci, Amato De Paulis, Amato De Paulis, Ilaria Mormile, Marco Zurlo, Marco Zurlo, Mario Di Gioacchino, Vincenzo Patella, Vincenzo Patella, Stefano Del Giacco, Giulia Costanzo, Simone Negrini, Simone Negrini, Giovanni Rolla, Luisa Brussino
Published 2025-07-01Hypereosinophilic syndrome (HES) is a heterogeneous group of disorders characterised by persistent hypereosinophilia associated with organ damage. Due to its rarity and heterogeneity in its clinical presentation, HES remains underdiagnosed or misdiagnosed, often leading to delayed diagnosis and irre...
Get full text
Article